RELAX: Reducing Length of Antibiotics for Children With Ear Infections

Acute Otitis Media Clinical Trial

— RELAX  

Official title:

RELAX: Reducing Length of Antibiotics for Children With Ear Infections

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05608993
• Other study ID #: 22-1528
• Secondary ID: 1R01HS029153-01
• Status: Not yet recruiting
• Phase: N/A
• Start date: April 2024
• Est. completion date: October 2027

Study information

• Verified date: March 2024
• Source: Denver Health and Hospital Authority
• Contact: Amy Keith, MPH
• Phone: 303-602-7198
• Email: amy.keith[@]dhha.org
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The overarching goal of this study is to evaluate the effectiveness and implementation outcomes of two low-cost interventions of different intensities to increase prescribing of recommended short antibiotic durations for acute otitis media (AOM) for children 2 years of age and older. A multi-center cluster randomized controlled trial using a hybrid type 2 implementation effectiveness design will be used to evaluate interventions. The High-Intensity intervention will include clinician education, individualized clinician audit and feedback with peer comparison, and electronic health record (EHR) changes of prescription fields, whereas the Low-Intensity intervention will include clinician education and EHR changes. In total, 46 community-based clinics and/or urgent care centers across two distinct geographic regions in the United States will be randomized to one of the two interventions. The Practical Robust Implementation and Sustainability Model (PRISM) will be used to guide implementation and the Reach Effectiveness Adoption Implementation Maintenance (RE-AIM) framework will be used to evaluate outcomes. A mixed-methods approach will be used in the pre-implementation and evaluation phases and will utilize quantitative analyses, semi-structured interviews, focus groups, surveys, and cost analyses. National stakeholders at the American Academy of Pediatrics and the Centers for Disease Control and Prevention will assist with dissemination of findings and scaling of interventions.

Description:

Acute otitis media (AOM) is the most commonly cited indication for antibiotics in children, accounting for 24% of all pediatric antibiotic prescriptions and affecting 60% of children by 3 years of age. For most children ≥ 2 years of age with AOM, 5-7 days, rather than 10 days, of antibiotics have been shown to be sufficient and result in fewer adverse drug events with similar failure and recurrence rates. Thus, national guidelines recommend short durations of antibiotics for non-severe AOM in this age group. Despite these recommendations, >94% of children ≥2 years of age are prescribed longer than recommended antibiotic durations and over 41% of antibiotic exposure days for AOM in this age group are likely unnecessary. In a recent pilot study that compared a low-cost High-intensity intervention with clinician education, individualized clinician audit and feedback with peer comparison and electronic health record (EHR) changes of prescription fields to a Low-intensity intervention with only EHR changes prescribing of recommended short antibiotic durations increased significantly (76% and 50%, absolute percentage). A definite study is needed to make appropriate recommendations on which intervention to implement, while minimizing resource utilization. The overarching goal of this study is to evaluate the effectiveness and implementation outcomes of two low-cost pragmatic interventions of different intensities to increase prescribing of recommended short antibiotic durations for AOM for children 2 years of age and older. A multi-center cluster randomized controlled trial using a hybrid type 2 implementation effectiveness design will be used to evaluate interventions. The High-intensity intervention will include clinician education, individualized clinician audit and feedback with peer comparison, and EHR changes of prescription fields, whereas the Low-intensity intervention will include clinician education and EHR changes. In total, 46 community-based clinics and/or urgent care centers across two distinct geographic regions in the United States will be randomized to one of the two interventions. The Practical Robust Implementation and Sustainability Model will be used to guide implementation and the Reach Effectiveness Adoption Implementation Maintenance framework will be used to evaluate outcomes. A mixed-methods approach will be used in the pre-implementation and evaluation phases and will utilize quantitative analyses, semi-structured interviews, focus groups, surveys, and cost analyses.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 500
• Est. completion date: October 2027
• Est. primary completion date: April 2027
• Accepts healthy volunteers: No
• Gender: All
• Age group: 2 Years to 17 Years

Eligibility

Inclusion Criteria:

A. Secondary use data of encounters for children with AOM

1. Aged 2-17-years-old (inclusive)

2. Diagnosis of AOM by ICD10 code

3. AOM is uncomplicated

4. Prescribed an oral antibiotic B. Clinician and administrator interviews

1. Licensed clinician (physician or advanced practice clinician) that cares for children with AOM

2. Practices in an intervention study site

3. Is not a medical trainee (student, resident, fellow, etc.)

4. Aged >=18 years-no maximum C. Parent focus groups

1. Parent or legal guardian of a child aged 2-17 years that has had AOM diagnosed at Vanderbilt University Medical Center or Washington University

2. 18 years of age or older and able/willing to consent D. Clinician and administrator surveys

1. Licensed clinician (physician or advanced practice clinician) that cares for children with AOM

2. Practices in an intervention study site

3. Is not a medical trainee (student, resident, fellow, etc.)

4. Aged >=18 years-no maximum Exclusion Criteria: A. Secondary use data of encounters for children with AOM

1. Complicated infection (determined a priori) B. Clinician and administrator interviews 1. Medical trainee C. Parent focus groups

1. Not parent or legal guardian

2. Does not speak English or Spanish (focus groups can only be conducted in these languages). D. Clinician and administrator surveys

1. Medical trainee

Related Conditions & MeSH terms

• Acute Otitis Media
• Communicable Diseases
• Ear Infection
• Infections
• Otitis
• Otitis Media
• Pediatric Infectious Disease

Intervention

Other:
• High Intensity Intervention
The High Intensity intervention will include clinician education, individualized clinician audit and feedback with peer comparison, and electronic health record (EHR) changes of prescription fields.
• Low Intensity Intervention
The Low Intensity intervention will include clinician education and EHR changes only.

Locations

Country	Name	City	State
n/a

Sponsors (4)

Lead Sponsor	Collaborator
Denver Health and Hospital Authority	Agency for Healthcare Research and Quality (AHRQ), Vanderbilt University Medical Center, Washington University School of Medicine

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Proportion of children = 2 years of age with AOM that are prescribed a short duration (5 days) of antibiotics.	Determine the effectiveness of a High and Low intensity intervention to increase prescribing of recommended antibiotic durations (short, 5 days) for AOM in children = 2 years of age.	5 years
Secondary	Mean days of antibiotics prescribed	Mean number of days of antibiotics prescribed for children = 2 years of age with AOM	5 years
Secondary	Adverse drug event	Number of adverse drug events among children = 2 years of age prescribed antibiotics for AOM	5 years
Secondary	Treatment failure	Treatment failure defined as a new antibiotic associated with an AOM encounter within 3-14 days of the initial encounter.	5 years
Secondary	Recurrence	Recurrence defined as a new antibiotic associated with an AOM encounter within 15-30 days of initial encounter.	5 years